The Scientific Council – Scientific Advisatory Board

The scientific council is made up of 8 internationally renowned researchers covering the five SIRIC disciplines (clinical, biological, epidemiology, public health, human and social sciences) with expertise in the three BRIO programs, as well as a patient also researcher. The role of the SAB is to provide an expert opinion on BRIO‘s research strategy and results. The progress of SIRIC is presented to the SAB once a year.

Presentation of the 9 members of the SAB:

Prof. David Cameron
Clinical Director and Chair of Oncology,
Cancer Research
Edinburgh, UK

Prof. Stephan Sleijfer
Head of department, Medical Oncology,
Erasmus MC Rotterdam
Rotterdam, Netherlands

Dr Valery Krizhanovsky
Group Head – cellular senescence in tissue damage,
cancer and aging, Weizmann Institute of Science
Rehovot, Israel

Prof. Janet Shipley
Team Leader, Sarcoma Molecular Pathology,
The Institute of Cancer Research
London, UK

Prof. Viktor Umansky
German Cancer Research Center
(DKFZ)
Halle, Germany

Prof. Frédéric Paccaud
Directeur de l’Institut universitaire de médecine sociale et préventive (IUMSP).
Professeur d’épidémiologie et de santé publique,
Faculté de biologie et médecine de l’Université de Lausanne
Lausanne, Switzerland

Dr Nicolas Leupin
Chief Medical Officer
at Argenx
Zürich, Switzerland

Dr Amaury Dumont
Senior Medical Manager Cell therapy,
Gilead / Kite
Boulogne-Billancourt, France

Dr Audrey Brussel
Ex-patiente
Meudon, France